BDC Conversion And Federal Shifts Will Expand Lending Across Sectors

Published
26 Sep 24
Updated
20 Aug 25
AnalystConsensusTarget's Fair Value
US$7.50
45.2% undervalued intrinsic discount
20 Aug
US$4.11
Loading
1Y
-59.7%
7D
1.5%

Author's Valuation

US$7.5

45.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update16 Aug 25
Fair value Decreased 14%

Despite a dramatic increase in revenue growth forecasts and a lower projected future P/E, the consensus analyst price target for Advanced Flower Capital has been revised downward from $8.76 to $7.50.


What's in the News


  • Advanced Flower Capital declared a quarterly dividend of $0.15 per common share for the quarter ending June 30, 2025, payable on July 15, 2025 to shareholders of record on June 30, 2025.

Valuation Changes


Summary of Valuation Changes for Advanced Flower Capital

  • The Consensus Analyst Price Target has significantly fallen from $8.76 to $7.50.
  • The Consensus Revenue Growth forecasts for Advanced Flower Capital has significantly risen from 19.2% per annum to 103.1% per annum.
  • The Future P/E for Advanced Flower Capital has significantly fallen from 6.49x to 5.26x.

Key Takeaways

  • Broadening the investment mandate and transitioning to a BDC will expand AFC's addressable market, borrower diversity, and revenue growth opportunities.
  • Limited competition in cannabis finance and potential regulatory changes position AFC for stronger margins, asset recoveries, and resilient earnings.
  • Legacy loan issues, cannabis sector risks, strategic shift, financing constraints, and regulatory uncertainty threaten earnings stability, growth opportunities, and long-term profitability.

Catalysts

About Advanced Flower Capital
    Advanced Flower Capital Inc. originates, structures, underwrites, invests in, and manages senior secured loans and other types of mortgage loans and debt securities for established companies operating in the cannabis industry.
What are the underlying business or industry changes driving this perspective?
  • Expanding the investment mandate through proposed conversion to a BDC will allow AFC to lend to a far broader universe of cannabis operators-including those without real estate assets-as well as ancillary and non-cannabis middle market companies, which could significantly increase addressable market, pipeline size, and revenue growth.
  • Expected federal rescheduling of cannabis, if it materializes, would improve cash flows and valuations for borrowers by removing punitive tax regimes (e.g., 280E), likely reducing loan loss reserves and improving net margins and reported earnings via better recoveries on underperforming loans.
  • Increasing societal normalization and demand for cannabis continues to drive overall industry expansion, leading to more and larger borrowers and heightened need for non-bank finance, supporting sustained top line growth for AFC as it captures emerging opportunities.
  • Continued banking hesitancy toward the cannabis sector provides AFC with strong pricing power and limited direct competition in specialty finance, helping to maintain elevated loan yields and healthy net interest margins compared to traditional REIT peers.
  • Diversification of the loan book across more borrowers, states, and industries-once the BDC transition is complete-reduces concentration risk and the impact of individual credit events, leading to improved revenue stability and resilience in distributable earnings.

Advanced Flower Capital Earnings and Revenue Growth

Advanced Flower Capital Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Advanced Flower Capital's revenue will grow by 103.1% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -107.2% today to 64.1% in 3 years time.
  • Analysts expect earnings to reach $46.9 million (and earnings per share of $2.03) by about August 2028, up from $-9.4 million today.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 4.7x on those 2028 earnings, up from -8.9x today. This future PE is lower than the current PE for the US Mortgage REITs industry at 13.7x.
  • Analysts expect the number of shares outstanding to grow by 2.92% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 6.78%, as per the Simply Wall St company report.

Advanced Flower Capital Future Earnings Per Share Growth

Advanced Flower Capital Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • The company is still dealing with a significant number of underperforming and troubled legacy loans, including assets in liquidation and loans on nonaccrual status, which continues to pressure earnings, increase loan loss reserves, and contribute to a large GAAP net loss, putting ongoing strain on distributable earnings and net margins.
  • Advanced Flower Capital has a portfolio concentrated in the cannabis sector, which remains subject to continued industry volatility, limited capital inflows, and ongoing legal and regulatory risks due to federal prohibition, increasing potential for asset impairments and write-downs that could reduce revenue and earnings stability.
  • The announced conversion from a REIT to a BDC broadens the investment universe but introduces new risks, as lending to operators without real estate collateral may elevate credit risk and reduce recovery rates in defaults, which may negatively affect future net interest margins, loan quality, and earnings.
  • Heavy reliance on external financing and a limited willingness to issue equity given discounted stock price constrains AFC's ability to fund new growth, leaving the company exposed to capital market volatility and potentially limiting expansion of revenue and earnings if credit conditions tighten.
  • Uncertainty around federal rescheduling and potential regulatory change creates execution risk; while more capital could flow into the industry and improve existing loan recoveries, greater banking acceptance and increased competition could erode AFC's market share, compress lending spreads, and negatively impact future revenue growth and long-term profitability.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of $7.5 for Advanced Flower Capital based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $13.0, and the most bearish reporting a price target of just $4.5.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $73.1 million, earnings will come to $46.9 million, and it would be trading on a PE ratio of 4.7x, assuming you use a discount rate of 6.8%.
  • Given the current share price of $3.7, the analyst price target of $7.5 is 50.7% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives